Skip to main content

Table 2 Results from the base case model and scenario analysis

From: Modelled cost-effectiveness analysis of the Support and Treatment After Replacement (STAR) care pathway for chronic pain after total knee replacement compared with usual care

 

STAR intervention

Usual care

Difference

  
 

QALYs

Costs £

QALYs

Costs £

∆ QALYs

∆ Costs £

iNMB*

Probability STAR intervention is cost-effective (PSA*)

Base case

3.18

3188.86

3.09

3563.45

0.086

-374.59

2086.09

0.62

Scenario 1 (QALY varies by CP/NCP and not by comparator)

3.16

3188.86

3.14

3563.45

0.020

-374.59

781.55

0.64

Scenario 2 (CP classification at 10 weeks)

3.18

3185.06

3.10

3476.38

0.082

-291.32

1924.61

0.61

Scenario 3 (No difference in hospital costs at year 1)

3.18

3141.79

3.09

3141.79

0.086

242.91

1468.59

0.59

  1. *iNMB and PSA analysis calculated with a threshold of £20,000
  2. STAR, Support and Treatment After Replacement; QALYs, quality-adjusted life years; iNMB, incremental net monetary benefit; PSA, probability sensitivity analysis; CP, chronic pain; NCP, non-chronic pain